Dermatology · Marion, OH
NPI
1245298009
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1063 Harding Memorial Pkwy
Marion, OH, 43302
Phone (740) 244-8550
Groups this clinician bills Medicare through
Medicare paid, 2024
$662K
57,073 services
Medicare patients, 2024
600
Average age 74
Drug cost, 2024
$8.1M
3,429 prescriptions
Company payments, 2025
$396K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George S Drew was code J7345 (aminolevulinic acid hcl for topical administration, 10% gel, 10 mg), 49,000 times for 72 patients. In total George S Drew billed 57,073 services in 83 codes, and Medicare paid $662K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-16.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 49,000 | 72 | $1.34 | $66K |
| G6001 Ultrasonic guidance for placement of radiation therapy fields | Office | 919 | 47 | $133.86 | $123K |
| 77280 Radiation Treatment Planning | Office | 849 | 44 | $199.08 | $169K |
| 77401 Conventional Radiation Treatment | Office | 840 | 45 | $30.74 | $26K |
| 99214 Office E&M - Established | Office | 780 | 435 | $83.88 | $65K |
| J3590 Unclassified biologics | Office | 661 | 14 | $0.02 | $10.23 |
| 17110 Destruction Skin Lesion | Office | 557 | 338 | $75.43 | $42K |
| 17000 Destruction Skin Lesion | Office | 550 | 343 | $27.60 | $15K |
| 17003 Destruction Skin Lesion | Office | 451 | 196 | $4.99 | $2,251 |
| 99211 Office E&M - Established | Office | 249 | 64 | $15.90 | $3,958 |
| 96573 Skin | Office | 242 | 72 | $163.58 | $40K |
| 99213 Office E&M - Established | Office | 164 | 145 | $65.31 | $11K |
| 99204 Office E&M - New | Office | 138 | 138 | $106.28 | $15K |
| 77336 Radiation Treatment Planning | Office | 134 | 44 | $65.86 | $8,825 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 120 | 20 | $0.54 | $65.33 |
By year: 2022 $373K for 8,977 services; 2023 $549K for 25,921 services; 2024 $662K for 57,073 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 31 | 30 | $8.37 | $260 |
Medicare prescription drug claims, 2024
In 2024, the drug George S Drew prescribed most often to Medicare patients was Dupixent Pen (Dupilumab), with 501 prescriptions and refills. In total George S Drew wrote 3,429 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dupixent Pen Dupilumab | 501 | 518 | 64 | $2.0M |
| Ammonium Lactate Generic | 388 | 530 | 209 | $8,171 |
| Ketoconazole Generic | 225 | 257 | 105 | $4,169 |
| Minoxidil Generic | 200 | 287 | 36 | $1,534 |
| Doxycycline Hyclate Generic | 127 | 153 | 53 | $5,076 |
| Triamcinolone Acetonide Generic | 126 | 169 | 75 | $2,136 |
| Opzelura Ruxolitinib Phosphate | 122 | 122 | 23 | $261K |
| Doxepin Hcl Generic | 117 | 155 | 31 | $1,740 |
| Rinvoq Upadacitinib | 108 | 108 | 14 | $761K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 91 | 96 | 11 | $752K |
| Clobetasol Propionate Generic | 85 | 96 | 46 | $3,232 |
| Metronidazole Generic | 85 | 101 | 42 | $3,556 |
| Imiquimod Generic | 71 | 78 | 56 | $2,559 |
| Taltz Autoinjector Ixekizumab | 67 | 67 | Under 11 | $453K |
| Siliq Brodalumab | 66 | 66 | Under 11 | $333K |
Brand drugs: 1,440 claims; generic drugs: 1,989 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George S Drew $396K ($396K in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $66K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 85 | $66K |
| Arcutis Biotherapeutics, Inc. ARQT | 41 | $41K |
| Janssen Biotech, Inc. JNJ | 38 | $36K |
| UCB, Inc. UCB.BR | 54 | $34K |
| Galderma Laboratories, L.P. GALD.SW | 37 | $28K |
| Regeneron Healthcare Solutions, Inc. REGN | 20 | $28K |
| Lilly USA, LLC LLY | 23 | $23K |
| Incyte Corporation INCY | 42 | $22K |
| Genzyme Corporation SNY | 19 | $21K |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 30 | $21K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.